B
Borko Jovanovic
Researcher at Northwestern University
Publications - 134
Citations - 7792
Borko Jovanovic is an academic researcher from Northwestern University. The author has contributed to research in topics: Prostate cancer & Hematopoietic stem cell transplantation. The author has an hindex of 43, co-authored 129 publications receiving 6837 citations. Previous affiliations of Borko Jovanovic include University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
Richard K. Burt,Sanjiv J. Shah,Karin E. Dill,Thomas H. Grant,Mihai Gheorghiade,James W. Schroeder,Robert M. Craig,Ikuo Hirano,Karin Marshall,Eric Ruderman,Borko Jovanovic,Francesca Milanetti,Francesca Milanetti,Sandeep Jain,Kristin Boyce,Amy Morgan,James C. Carr,Walter G. Barr +17 more
TL;DR: Non-myeloablative autologous HSCT improves skin and pulmonary function in patients with systemic sclerosis for up to 2 years and is preferable to the current standard of care, but longer follow-up is needed.
Journal ArticleDOI
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Adam M. Petrich,Mitul Gandhi,Borko Jovanovic,Jorge J. Castillo,Saurabh Rajguru,David T. Yang,Khushboo A Shah,Jeremy D. Whyman,Frederick Lansigan,Francisco J. Hernandez-Ilizaliturri,Lisa X Lee,Stefan K. Barta,Shruthi Melinamani,Reem Karmali,Camille Adeimy,Scott E. Smith,Neil Dalal,Chadi Nabhan,David Peace,Julie M. Vose,Andrew M. Evens,Namrata Shah,Timothy S. Fenske,Andrew D. Zelenetz,Daniel J. Landsburg,Christina Howlett,Anthony R. Mato,Michael Jaglal,Julio C. Chavez,Judy P. Tsai,Nishitha Reddy,Shaoying Li,Caitlin Handler,Christopher R. Flowers,Jonathon B. Cohen,Jonathon B. Cohen,Kristie A. Blum,Kevin W. Song,Haowei Linda Sun,Oliver W. Press,Ryan D. Cassaday,Jesse Jaso,L. Jeffrey Medeiros,Aliyah R. Sohani,Jeremy S. Abramson +44 more
TL;DR: In this article, the authors conducted a retrospective multicenter study of the impact of baseline clinical factors, induction therapy, and stem cell transplant (SCT) on the outcomes of 311 patients with previously untreated DHL.
Journal ArticleDOI
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.
Andrew M. Evens,Borko Jovanovic,Yu-Chieh Su,Dennis W. Raisch,Daniel Ganger,Steven M. Belknap,M.-S. Dai,B.-C. C. Chiu,Bara Fintel,Yan Cheng,S.-S. Chuang,M.-Y. Lee,T.-Y. Chen,S.-F. Lin,C.-Y. Kuo +14 more
TL;DR: The FDA AERS provided strong HBV-R safety signals; however, literature-based cases provided a significantly more complete description.
Journal ArticleDOI
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas
Mark Agulnik,Jessica L. Yarber,Scott H. Okuno,M. von Mehren,Borko Jovanovic,Bruce Brockstein,Andrew M. Evens,Robert S. Benjamin +7 more
TL;DR: Bvacizumab is an effective and well-tolerated treatment for metastatic or locally advanced angiosarcoma and epithelioid hemangioendotheliomas and in combination with other chemotherapeutic agents and/or radiation treatment are warranted.
Journal ArticleDOI
A meta-analysis of human acellular dermis and submuscular tissue expander breast reconstruction.
John Y.S. Kim,Armando A. Davila,Armando A. Davila,Scott Persing,Scott Persing,Caitlin M. Connor,Caitlin M. Connor,Borko Jovanovic,Seema A. Khan,Neil A. Fine,Vinay Rawlani,Vinay Rawlani +11 more
TL;DR: The meta-analysis suggests that the use of human acellular dermal matrix increases complication rates vis-à-vis submuscular expander/implant reconstruction, which must be weighed against its reported advantages in enhancing cosmesis and ameliorating contracture.